Free Trial

Vir Biotechnology (VIR) SEC Filings & 10K Form

Vir Biotechnology logo
$5.49 +0.08 (+1.48%)
Closing price 04:00 PM Eastern
Extended Trading
$5.55 +0.06 (+1.09%)
As of 07:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Vir Biotechnology SEC Filings

DateFilerForm TypeView
07/15/2025
7:11 PM
Eisner Mark (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
4:59 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
4:04 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
5:39 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
4:55 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
7:26 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:22 PM
MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:26 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:27 PM
Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:28 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:31 PM
Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:17 PM
BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:19 PM
Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:20 PM
Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
7:23 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2025
12:02 PM
BlackRock, Inc. (Filed by)
Vir Biotechnology (Subject)
Form SCHEDULE 13G/A
04/17/2025
8:27 AM
Vir Biotechnology (Filer)
Form ARS
04/17/2025
7:40 AM
Vir Biotechnology (Filer)
Form DEFA14A
04/17/2025
7:33 AM
Vir Biotechnology (Filer)
Form DEF 14A
04/04/2025
3:23 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:50 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
11:39 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:01 AM
Vir Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:23 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
2:43 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:44 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:34 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:36 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:37 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:39 PM
Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
2:41 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
7:56 PM
HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:57 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:38 PM
De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
7:40 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
6:11 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:50 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
5:41 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
5:49 PM
Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
01/30/2025
6:51 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:03 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
3:22 PM
SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
6:50 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
12:36 PM
O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:20 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
4:51 PM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
3:20 PM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:26 PM
SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
11:29 AM
STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
Form SC 13G/A
10/02/2024
11:09 AM
Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2024
11:07 AM
de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2024
3:28 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
7:10 AM
Vir Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:29 PM
Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:43 PM
Vir Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIR) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners